E-LIB Suche - Ergebnisse für: Vaishampayan, U.

1

Patients experience with recurrence of renal cell carcinoma:

Rodler, S. ; Goetz, M. ; Graser, A....
European Urology. 83 (2023) - p. S681 , 2023

Link: https://doi.org/10.1016/..

2

204P Phase Ib study of gedatolisib plus palbociclib and end..:

Rugo, H.S. ; Wesolowski, R. ; Stringer-Reasor, E....
ESMO Open. 8 (2023) 1 - p. 101393 , 2023

Link: https://doi.org/10.1016/..

3

1O Safety, pharmacokinetics, efficacy, and biomarker result..:

Yap, T.A. ; Gainor, J. ; McKean, M....
ESMO Open. 8 (2023) 1 - p. 100967 , 2023

Link: https://doi.org/10.1016/..

4

Unraveling the functional dark matter through global metage..:

Pavlopoulos, Georgios A ; Baltoumas, Fotis A ; Liu, Sirui...
https://oceanrep.geomar.de/id/eprint/59876/1/s41586-023-06583-7.pdf. , 2023

Link: https://oceanrep.geomar...

5

Subasumstat, a first-in-class inhibitor of SUMO-activating ..:

Saggu, G. ; Stroopinsky, D. ; Dudek, A.Z....
European Journal of Cancer. 174 (2022) - p. S125-S126 , 2022

Link: https://doi.org/10.1016/..

6

First-in-human phase 1 study of the anti-TIGIT antibody vib..:

Niu, J. ; Maurice-Dror, C. ; Lee, D.H....
Annals of Oncology. 33 (2022) 2 - p. 169-180 , 2022

Link: https://doi.org/10.1016/..

7

First-in-human phase 1 study of the anti-TIGIT antibody vib..:

Niu, J ; Maurice-Dror, C ; Lee, D. H...
Annals of Oncology, Vol.33 No.2, pp.169-180. , 2022

Link: https://hdl.handle.net/1..

8

Predictive biomarkers for survival benefit with ramucirumab..:

van der Heijden, MS ; Powles, T ; Petrylak, D...
https://eprints.whiterose.ac.uk/186635/1/Predictive%20biomarkers%20for%20survival%20benefit%20with%20ramucirumab%20in%20urothelial%20cancer%20in%20the%20RANGE%20trial.pdf. , 2022

Link: https://eprints.whiteros..

9

A randomized phase IIa study of quantified bone scan respon..:

Petrylak, D.P. ; Vaishampayan, U.N. ; Patel, K.R....
ESMO Open. 6 (2021) 2 - p. 100082 , 2021

Link: https://doi.org/10.1016/..

10

A randomised phase II trial of three dosing regimens of rad..:

Sternberg, C.N. ; Saad, F. ; Graff, J.N....
Annals of Oncology. 31 (2020) 2 - p. 257-265 , 2020

Link: https://doi.org/10.1016/..

11

KEYNOTE-199 cohorts 4 and 5: Pembrolizumab (pembro) plus en..:

McDermott, R. ; Graff, J.N. ; Antonarakis, E.S....
European Urology Open Science. 19 (2020) - p. e885-e886 , 2020

Link: https://doi.org/10.1016/..

12

Pembrolizumab (pembro) for docetaxel-pretreated metastatic ..:

Piulats, J.M. ; Antonarakis, E.S. ; Gross-Goupil, M....
European Urology Open Science. 19 (2020) - p. e877-e878 , 2020

Link: https://doi.org/10.1016/..

13

A randomised phase II trial of three dosing regimens of rad..:

Sternberg, C. N ; Saad, F ; Graff, J. N...
Sternberg , C N , Saad , F , Graff , J N , Peer , A , Vaishampayan , U N , Leung , E , Rosenbaum , E , Gurney , H , Epstein , R J , Davis , I D , Wu , B , Trandafir , L , Wagner , V J & Hussain , M 2020 , ' A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer ' , Annals of Oncology , vol. 31 , no. 2 , pp. 257-265 . https://doi.org/10.1016/j.annonc.2019.10.025. , 2020

Link: https://research.monash...

14

KEYNOTE-199 cohorts 4 and 5: Pembrolizumab (pembro) plus en..:

R. McDermott ; J.N. Graff ; E.S. Antonarakis...
http://www.sciencedirect.com/science/article/pii/S2666168320331712. , 2020

Link: https://doi.org/10.1016/..

15

Pembrolizumab (pembro) for docetaxel-pretreated metastatic ..:

J.M. Piulats ; E.S. Antonarakis ; M. Gross-Goupil...
http://www.sciencedirect.com/science/article/pii/S2666168320331669. , 2020

Link: https://doi.org/10.1016/..